FAQs in Peanut Allergy: Exploring Unanswered Questions Following Allergy Meeting Updates
FAQs in Peanut Allergy: Exploring Unanswered Questions Following Allergy Meeting Updates is organized by Physicians' Education Resource, LLC (PER).
Release Date: March 27, 2023
Expiration Date: March 27, 2024
Description:
The PER FAQ™ is an innovative video-based activity that features a clinical expert answering questions submitted by learners who participated in a related PER Postgame™ activity. It is intended to provide useful commentary about important research-related or point-of-care-focused questions that many clinicians face in daily practice. This activity is based on the PER Postgame™ activity PER Postgame™: The Latest from Louisville 2022 – Utilizing Recent Data to Improve Care for Patients with Peanut Allergy that reviews abstracts presented at relevant 2022 annual allergy meetings regarding clinical trial data for current and emerging therapies for peanut allergy.
Learning Objectives:
Upon successful completion of this activity, you should be better prepared to:
• Analyze recent efficacy and safety data of novel oral immunotherapy (OIT) agents that have the potential to substantially impact outcomes in patients with peanut allergies
• Design optimal treatment plans for toddlers with peanut allergies based on the latest clinical trial data findings regarding OIT agents.